Beijing: September 6, 2020. China National Biotec Group (CNBG) para COVID vaccine bona te phase 3 clinical trials samay Duniyaa sob para melaikena 50,000 neshina manuh khan thakibo koikena, Saturday din Company para press release te koishe. “COVID-19 oper te bonai thaka clinical trials active nakora third phase toh besi bhal para jaiase aro clinical trials toh besi alag-alag desh te loiase, desh neshina Bahrain, UAE, Morocco, Peru, Argentina, para 50,000 neshina manuh khan part loboli ase koikena CNGB para janai thishe. July moina te Media para khobor thishe ke, CNBG’s vaccine laga phase 3 trial toh be Uzbekistan, aro Pakistan desh para interest ase aro tai be clinical trials koriboli janai thishe koishe.
China: Phase 3 Trial samay 50,000 manuh thakibo
Add Comment